LPL Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-13,055
Closed -$189K – 4463
2022
Q2
$189K Buy
13,055
+1,929
+17% +$32.9K ﹤0.01% 3976
2022
Q1
$291K Sell
11,126
-218
-2% -$6.18K ﹤0.01% 3583
2021
Q4
$449K Sell
11,344
-5,033
-31% -$229K ﹤0.01% 3370
2021
Q3
$819K Sell
16,377
-192
-1% -$10.5K ﹤0.01% 2789
2021
Q2
$920K Sell
16,569
-1,598
-9% -$85.1K ﹤0.01% 2638
2021
Q1
$850K Buy
18,167
+210
+1% +$10.2K ﹤0.01% 2543
2020
Q4
$782K Sell
17,957
-258
-1% -$9.52K ﹤0.01% 2385
2020
Q3
$667K Buy
18,215
+7,151
+65% +$243K ﹤0.01% 2234
2020
Q2
$323K Buy
11,064
+1,194
+12% +$33K ﹤0.01% 2786
2020
Q1
$258K Buy
+9,870
New +$302K ﹤0.01% 2616

Other funds holding HCAT

LPL Financial's HCAT Position: Q3 2022 in Review

LPL Financial sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 13,055 shares — an estimated $189K sold.

LPL Financial first reported a position in HCAT in Q1 2020 and held it in 10 quarters. The position peaked at $920K in Q2 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

  • LPL Financial reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
  • LPL Financial sold 13,055 Health Catalyst shares in Q3 2022, an estimated $189K.
  • LPL Financial first reported a position in Health Catalyst in Q1 2020 and held it in 10 quarters.
  • LPL Financial's Health Catalyst position peaked at $920K in Q2 2021.
  • 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on LPL Financial's 13F filing for Q3 2022, filed 14 Nov 2022.